Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient
<h3>Background</h3><p dir="ltr">Vaccines were developed and deployed to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to characterize patterns in the protection provided by the BNT162b2 and mRNA-1273 mRNA vaccines against...
محفوظ في:
مواد مشابهة
-
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient
حسب: Layan, Sukik
منشور في: (2024) -
Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection
حسب: Haissam Abou-Saleh (497840)
منشور في: (2022) -
Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months
حسب: Salma, Younes
منشور في: (2023) -
The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
حسب: Ahmed Zaqout (9538566)
منشور في: (2021) -
Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting
حسب: Salma, Younes
منشور في: (2024)